Jazz Pharmaceuticals plc Quarterly Other Assets, Noncurrent in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Jazz Pharmaceuticals plc quarterly Other Assets, Noncurrent history and growth rate from Q4 2010 to Q3 2024.
  • Jazz Pharmaceuticals plc Other Assets, Noncurrent for the quarter ending September 30, 2024 was $75.2M, a 1.12% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $75.2M -$849K -1.12% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $71.4M +$5.45M +8.26% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $70.8M +$6.7M +10.5% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $67.5M +$12.3M +22.4% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $76.1M +$40.9M +116% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $66M +$31.4M +90.6% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $64.1M +$28.6M +80.5% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $55.1M +$14.3M +35.1% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $35.2M -$10.6M -23.2% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $34.6M -$12.5M -26.5% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $35.5M +$5.16M +17% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $40.8M +$15.1M +58.7% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $45.8M +$7.13M +18.5% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $47.1M -$1.75M -3.58% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $30.4M -$16.8M -35.6% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $25.7M -$22.2M -46.3% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $38.6M -$5.63M -12.7% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $48.8M +$7.99M +19.6% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $47.1M +$6.37M +15.6% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $47.9M +$5.22M +12.2% Dec 31, 2019 10-K 2021-02-23
Q3 2019 $44.3M -$11.7M -20.9% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $40.8M +$17.4M +74.5% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $40.7M +$17.8M +77.2% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $42.7M +$26.3M +160% Dec 31, 2018 10-K 2020-02-25
Q3 2018 $56M +$39.6M +241% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $23.4M +$6.77M +40.7% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $23M +$5.36M +30.4% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $16.4M +$2.36M +16.8% Dec 31, 2017 10-K 2019-02-26
Q3 2017 $16.4M -$21.3M -56.5% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $16.6M -$20.4M -55% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $17.6M -$11.9M -40.3% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $14.1M +$4.79M +51.7% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $37.8M +$12.4M +48.7% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 $37M +$14.5M +64.5% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $29.5M +$10.4M +54% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $9.27M -$6.66M -41.8% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $25.4M +$11.9M +88.3% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $22.5M +$11.4M +102% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $19.2M +$9.89M +106% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $15.9M +$8.63M +118% Dec 31, 2014 10-K 2016-02-23
Q3 2014 $13.5M +$7.09M +111% Sep 30, 2014 10-Q 2014-11-04
Q2 2014 $11.1M +$5.63M +102% Jun 30, 2014 10-Q 2014-08-05
Q1 2014 $9.3M +$4.75M +104% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $7.3M +$3.64M +99.5% Dec 31, 2013 10-K 2015-02-24
Q3 2013 $6.39M -$14M -68.7% Sep 30, 2013 10-Q 2013-11-05
Q2 2013 $5.5M -$13.7M -71.4% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $4.55M +$4.16M +1081% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 $3.66M +$3.58M +4109% Dec 31, 2012 10-K 2014-02-25
Q3 2012 $20.4M +$20.3M +24484% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $19.2M +$19.1M +12549% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $385K Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $87K -$248K -74% Dec 31, 2011 10-K 2013-02-26
Q3 2011 $83K Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $152K Jun 30, 2011 10-Q 2011-08-03
Q4 2010 $335K Dec 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.